National guidelines for PrEP medications
Many organizations across the US have recommendations about PrEP for the prevention of HIV
IAS–USA
International Antiviral Society–USA
The IAS—USA recommends discussing and offering PrEP to all sexually active persons, and encourages populations with disproportionately high HIV incidence rates to consider PrEP as part of their HIV prevention plans.1
CDC
Centers for Disease Control and Prevention
The CDC recommends that all sexually active adults and adolescents should be informed about PrEP for prevention of HIV.2
DHHS
US Department of Health and Human Services
The National HIV/AIDS Strategy includes PrEP medication as one of the key prevention strategies toward its goal for ending the HIV epidemic in the United States by 2030.3,4
USPSTF
US Preventive Services Task Force
The USPSTF issued a Grade A recommendation for PrEP medication for people who have an increased likelihood of HIV acquisition.5
How it may benefit individuals who are prescribed PrEP:
As a result of the USPSTF Grade A recommendation, the Affordable Care Act (ACA) requires most plans* to cover medically appropriate PrEP medications, such as DESCOVY FOR PrEP®, and ancillary services, with no out-of-pocket costs.6
Don’t let cost be a barrier to PrEP
Educate people who may benefit from PrEP medication that many health plans should provide coverage and zero co-pay or coinsurance for medically appropriate PrEP medications and ancillary services.
Encourage individuals to contact their health plans for more information to understand their coverage.
When prescribing a PrEP medication, consider clinical guidelines and recommendations from various health organizations.
*The ACA applies to all nongrandfathered private plans and Medicaid expansion plans.
BMD=bone mineral density; HBV=hepatitis B virus; HCV=hepatitis C virus; STI=sexually transmitted infection.